04/02/2015 - 7:52am

Sam's Club on Thursday sweetened the pot for its Plus and Business Plus members with an offering of five generic prescriptions without charge in most states. 

04/01/2015 - 11:47am

Dr. Reddy's Laboratories on Wednesday acquired UCB's portfolio of dermatology, respiratory and pediatric products. 

04/01/2015 - 10:54am

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

03/31/2015 - 3:57pm

The director of the FDA’s Office of Generic Drugs temporarily steps down to deal with a medical issue, according to a report by the Regulatory Focus Professionals Society.

03/31/2015 - 10:39am

Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed. 

03/31/2015 - 9:29am

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

03/30/2015 - 10:50am

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.

03/27/2015 - 2:17pm

More than 350 pharmacy advocates headed to Capitol Hill for the seventh annual NACDS RxIMPACT Day to further reinforce the recognition by lawmakers of the evolving role of pharmacy in patient care and educate members of Congress about pro-patient, pro-pharmacy policy.

03/27/2015 - 10:51am

The Food and Drug Adminisration on Friday revisited the issue of supplemental applications proposing labeling changes for approved drugs and biologic products.